CALC
CalciMedica, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C
Company Profile
CEO
A. Rachel Leheny
IPO Date
2023-06-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
CalciMedica, Inc.
CEO
A. Rachel Leheny
IPO Date
2023-06-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 91,173 |
| $0.58 |
| 7 Apr 2026 | Roberts Eric W | director, 10 percent owner, officer: CHIEF BUSINESS OFFICER | A-Award | Acquired | 83,358 | $0.58 |
| 7 Apr 2026 | Dunn Michael J. | President and COO | A-Award | Acquired | 65,124 | $0.58 |
| 7 Apr 2026 | Stauderman Kenneth A. | Chief Scientific Officer | A-Award | Acquired | 65,124 | $0.58 |
| 7 Apr 2026 | Leheny A. Rachel | director, 10 percent owner, officer: CHIEF EXECUTIVE OFFICER | A-Award | Acquired | 148,482 | $0.58 |
| 14 Oct 2025 | Glicklich Alan | director | A-Award | Acquired | 937 | $3.26 |
| 22 Sept 2025 | Roberts Eric W | director, 10 percent owner, officer: CHIEF BUSINESS OFFICER | P-Purchase | Acquired | 2,500 | $3.07 |
| 17 Sept 2025 | Roberts Eric W | director, 10 percent owner, officer: CHIEF BUSINESS OFFICER | P-Purchase | Acquired | 3,400 | $2.68 |
| 15 Sept 2025 | Roberts Eric W | director, 10 percent owner, officer: CHIEF BUSINESS OFFICER | P-Purchase | Acquired | 5,000 | $3.12 |